1. Technical Field
The present disclosure relates generally to non-invasive medical treatment procedures. In particular, the present disclosure relates to a method and system for treating body ailments or tissue conditions such as vascular disease, deep vein thrombosis, orthostatic intolerance, reduced blood flow, weak bone structure, orthostatic hypotension, or other conditions.
2. Background
Medical treatments for body ailments or tissue conditions that contact the outer surface of the body rarely, if ever, attain the maximum benefit possible. The condition of the patient may diminish the effectiveness of the medical treatment or make the entire treatment ineffective. For example, although compression devices can be applied to the surface of the body to reduce the incidence of a tissue condition such as deep vein thrombosis (DVT) in some patients, conditions such as swelling (edema), or obesity may diminish the effectiveness of the compression device and/or make the entire treatment ineffective. Moreover, adverse events during the treatment such as skin irritation, or pressure ulcer may be problematic and decrease the effectiveness of the treatment resulting in the need to discontinue or change the treatment and/or device to obtain a desired beneficial effect, or in some cases continue treatment subjecting the patient to prolonged discomfort.
Accordingly, there remains room for improvement in tissue treatment regimens for body ailments or tissue conditions. What are needed are new tissue treatment apparatuses and methods for treating body ailments and/or tissue conditions.
The present disclosure provides a low profile vibrating plate system for providing a medical treatment of body ailments or tissue conditions such as vascular disease, deep vein thrombosis, orthostatic intolerance, reduced blood flow, weak bone structure, orthostatic hypotension, or other conditions. The disclosed system includes a low profile base having a cavity, a platform having an upper portion and a lower portion, the platform in juxtaposed alignment with the low profile base. The platform is free moving within the cavity. The platform's upper portion provides a rigid base upon which a patient is to contact.
The apparatus in accordance with the present disclosure further includes a first magnetic layer positioned adjacent to the platform, the first magnetic layer configured for imparting periodic vibrations at a predetermined frequency to the platform. In some embodiments, a second magnetic layer is affixed to the lower surface of the cavity, and is aligned with the first magnetic layer for at least a portion of time and for at least a portion of time has polarity equal to the polarity of the first magnetic layer which results in repulsion of the first and second magnetic layers from one another. A controller in electrical communication with the second magnetic layer is configured for control of the polarity and magnetic field intensity of the second magnetic layer.
The first and second magnetic layers can be made of materials such as ferromagnetic objects, electromagnets, flexible magnets, injection molded magnets, neodymium iron boron magnets, samarium cobalt magnets, alnico magnets, ceramic magnets, or combinations thereof.
In some embodiments, the device is configured so the platform vibrates vertically and/or horizontally with a frequency of between 0 Hz and 10 KHz such as 30 Hz. Furthermore, in some embodiments, the platform vibrates vertically and/or horizontally for a distance of about 1 micrometer to about 40 micrometers. Stops may limit the distance to a predetermined displacement range.
In some embodiments, the device in accordance with the present disclosure is configured to have one or more elastic layers within the cavity of the low profile base. The elastic layers may be positioned between the first and second magnetic layers, and/or between the magnetic layers and the platform.
In some embodiments, the device in accordance with the present disclosure includes a third magnetic layer disposed upon the platform. Optionally, a fourth magnetic layer may be disposed upon the low profile base. In some embodiments, the third magnetic layer is configured to generate a static magnetic field and the fourth magnetic layer is configured to generate a dynamic magnetic field, having any combination of alternating polarities and varying magnetic field intensities.
Additionally, the present disclosure provides a method for using a low profile vibrating plate as a medical treatment of ailments or tissue conditions such as vascular disease, deep vein thrombosis, orthostatic intolerance, reduced blood flow, weak bone structure, orthostatic hypotension, or other conditions. The disclosed method provides a low profile base having a cavity and a platform dimensioned to fit within the cavity in a free moving manner. The platform provides a lower portion and an upper portion, wherein the upper portion provides a rigid base upon which a patient is to contact.
The disclosed method, additionally, provides for generating a first magnetic field using a first magnetic layer configured for generating a static magnetic field affixed to the platform's lower portion and a second magnetic layer configured for generating a dynamic magnetic field affixed to a lower surface of the cavity. The second magnetic layer is aligned with the first magnetic layer for at least a portion of time and for at least a portion of time has a polarity equal to the polarity of the first magnetic layer. The method further performs the step of controlling the dynamic magnetic field by adjustment of polarity and magnetic field intensity of the second magnetic layer.
The use of magnetic field generating devices in the embodiments of the present disclosure provides several key benefits. Magnetic field generating devices allow for a more compact form-factor for the vibrating plate, which allows for increased portability. Additionally, the devices can be set upon or within surfaces to facilitate use thereof.
In yet another embodiment, the present disclosure relates to a wearable apparatus for treating tissue ailments including a low profile base, a platform in juxtaposed alignment with the low profile base, the platform having an upper portion and a lower portion; and a first magnetic layer positioned adjacent to the platform, the first magnetic layer configured for imparting periodic vibrations at a predetermined frequency to the platform. The apparatus may be shaped to fit within a shoe or sandal. Furthermore, the apparatus may be incorporated into the body of a shoe or sandal. The apparatus may also include a vamp having a first end and a second end, both ends of the vamp being adjustably disposed within a track on the body of the apparatus. Accordingly, the vamp may be adjustable along the length of the apparatus.
In some embodiments, the upper portion of the platform is textured. Moreover, the apparatus may be disposed within the insole of a shoe. It is envisioned that the wearable apparatus may also include a second magnetic layer disposed upon the base, the second magnetic layer being aligned with the first magnetic layer, wherein the polarity of the first magnetic layer is substantially equal to the polarity of the second magnetic layer such that the first magnetic layer and the second magnetic layer repel one another. Accordingly, the platform can vibrate vertically and/or horizontally at a frequency of between 0 Hz and 10 KHz. Moreover, the platform can vibrate vertically and/or horizontally a distance of about 1 micrometer to about 40 micrometers.
In some wearable embodiments, a first elastic layer may be positioned between the first magnetic layer and the platform, and a second elastic layer may be positioned between the second magnetic layer and the first magnetic layer. A third magnetic layer may be disposed upon the platform, and a fourth magnetic layer may be disposed upon the low profile base.
These and other features, aspects, and advantages of the present disclosure will become better understood with regard to the following description, appended claims, and accompanying drawings wherein:
The present disclosure provides for the use of vibrational treatment in treating and preventing body ailments or tissue conditions. For example, apparatus and methods in accordance with the present disclosure are for therapeutically treating body ailments or tissue conditions such as vascular disease, deep vein thrombosis, orthostatic intolerance, reduced blood flow, weak bone structure, orthostatic hypotension, or other conditions. Furthermore, apparatus and methods in accordance with the present disclosure provide an oscillating platform apparatus that is highly stable, and substantially insensitive to the position of the patient thereon, while providing low displacement, high frequency mechanical loading of tissue sufficient to reduce, reverse, or prevent body ailments, tissue conditions, or other conditions. Moreover, the low profile device is suitable to be attached or set within surfaces such as flooring so that the benefits can be obtained by users during every day activities.
Referring to
In embodiments, the first magnetic layer 106a on the platform 104 include static magnetic field generating devices, such as permanent Ferro-magnets, but may also be electromagnets, coils, or dynamic magnetic field generating devices. In embodiments, the first magnetic layer is made of any suitable magnetic material such as one or more static ferromagnetic objects, electromagnets, flexible magnets, injection molded magnets, neodymium iron boron magnets, samarium cobalt magnets, alnico magnets, ceramic magnets, or combinations thereof. In one particular embodiment, first magnetic layer 106a is a flexible magnet configured to cover the underside of the platform 104. In embodiments, the first magnetic layer 106a can have a thickness of about 1 mm to about 5 cm.
The second magnetic layer 106b, can be a set of electromagnets, coils, or other dynamic magnetic field generating devices. In embodiments, the second magnetic layer 106b, can be one or more static ferromagnetic objects, electromagnets, flexible magnets, injection molded magnets, neodymium iron boron magnets, samarium cobalt magnets, alnico magnets, ceramic magnets, or combinations thereof. In one particular embodiment, second magnetic layer 106b is a flexible magnet configured to coat and/or cover the low platform base 102. In embodiments, the second magnetic layer can have a thickness of about 1 mm to about 5 cm.
By varying the field intensity and/or alternating the polarity of the second magnetic layer 106b to create a dynamic magnetic field, a vertical vibration of the platform 104 can be induced. The vibrational frequency is determined by the rate of change of the magnetic properties, while the amplitude of the vibration is determined by the magnetic field intensity. Additionally, the magnetic field intensity may be increased or decreased as needed, depending on a patient's weight, to properly position and vibrate the platform 104.
In embodiments, the field intensity and/or alternating of the polarity of the second magnetic layer 106b is configured for imparting periodic vibrations at a predetermined frequency to the platform 104. Accordingly, in embodiments, the platform 104 vibrates vertically with a frequency of between 0 Hz and 10 KHz. In particular embodiments, the platform 104 vibrates vertically with a frequency of about 30 KHz. In embodiments, the platform vibrates vertically a distance of about 1 micrometer to about 40 micrometers.
In embodiments, the field intensity and/or alternating of the polarity of the second magnetic layer 106b can be controlled by sending a signal to processor 108 in electrical communication with the second magnetic layer 106b. The signal can be sent manually and/or remotely by signaling with infrared, radiofrequency, or any other signal available in the electromagnetic spectrum.
To limit travel of the platform 104, one or more stops 109 may be affixed to the low profile base 102 at the upper limit of the platform's 104 travel, thus preventing the platform 104 from separating from the low profile base 102. The stops 109 may be bumpers in this case, or alternatively, the stops may be a cable, spring or elastic band connected to the underside of the platform 104 and the bottom of the cavity of the low profile base 102.
Referring to
Aligned directly below the first magnetic layer 206 is a second magnetic layer 208 configured to generate a magnetic field, which is controllable as described above for the embodiment in
Referring to
As the horizontal arm 312 rotates, the magnets 306b align and unalign periodically with magnetic layers 306a attached to the underside of the platform 304. The magnetic layers 306a and 306b are configured to provide repulsive force against each other, so that, upon alignment of the magnetic layers 306a and 306b, the platform 304 is levitated upward and upon unalignment, the repulsive force is removed allowing the platform 304 to drop downward. The speed at which the motor 310 rotates the magnetic layers 306b directly determines the vibrational frequency of the plate, thus by varying the rotational speed of the motor 310, the frequency is adjusted to provide optimal therapeutic benefit to the patient. In embodiments, the magnetic layer 306a and 306b are capable of generating a magnetic field and can be a permanent Ferro-magnetic device, and/or made of any suitable magnetic material such as one or more static or dynamic ferromagnetic objects, electromagnets, flexible magnets, injection molded magnets, neodymium iron boron magnets, samarium cobalt magnets, alnico magnets, ceramic magnets, or combinations thereof.
The flowchart of
Referring to
Aligned directly below the first magnetic layer 506 is a second magnetic layer 508 configured for generating a magnetic field, which is controllable as described above for the embodiment in
Additionally, a third magnetic layer 510 configured for generating a magnetic field is positioned along at least one side of the platform 504. As with the first magnetic layer 506, the third magnetic layer 510 can be made from permanent Ferro-magnetic materials and/or any suitable magnetic material such as one or more static or dynamic ferromagnetic objects, electromagnets, flexible magnets, injection molded magnets, neodymium iron boron magnets, samarium cobalt magnets, alnico magnets, ceramic magnets, or combinations thereof.
A fourth magnetic layer configured for generating a magnetic field 512 is located and aligned opposite the third magnetic layer 510 on a side wall of the cavity of the low profile base 502. The fourth magnetic layer 512 is controllable in the same manner as described for the second magnetic layer 508, such that a controlled horizontal vibration is imparted on the platform 504. By alternating the magnetic polarity of the fourth magnetic layer 512, a horizontal vibration of the platform 504 is induced. Additional magnet layers may be placed on a perpendicular side of the platform 504 and cavity wall to induce a third dimension of vibration of the platform 504.
In embodiments, the field intensity and/or alternating of the polarity of the fourth magnetic layer 512 is configured for imparting periodic vibrations at a predetermined frequency to the platform 504. Accordingly, in embodiments, the platform 504 vibrates horizontally with a frequency of between 0 Hz and 10 KHz. In particular embodiments, the platform 504 vibrates horizontally with a frequency of about 30 Hz.
Referring to
In embodiments, the first magnetic layer 606a below first elastic layer 610 includes static magnetic field generating devices, such as permanent Ferro-magnets, but may also include electromagnets, coils, or dynamic magnetic field generating devices. In embodiments, the first magnetic layer 606a is made of any suitable magnetic material such as one or more static ferromagnetic objects, electromagnets, flexible magnets, injection molded magnets, neodymium iron boron magnets, samarium cobalt magnets, alnico magnets, ceramic magnets, or combinations thereof. In one particular embodiment, first magnetic layer 606a is a flexible magnet configured to cover the underside of the first elastic layer 610. In embodiments, the first magnetic layer 606a can have a thickness of about 1 mm to about 5 cm.
The second magnetic layer 606b, can be a set of electromagnets, coils, or other dynamic magnetic field generating devices. In embodiments, the second magnetic layer 606b, can be one or more static ferromagnetic objects, electromagnets, flexible magnets, injection molded magnets, neodymium iron boron magnets, samarium cobalt magnets, alnico magnets, ceramic magnets, or combinations thereof. In one particular embodiment, second magnetic layer 606b is a flexible magnet configured to coat or cover the low platform base 602. In embodiments, the second magnetic layer can have a thickness of about 1 mm to about 5 cm.
By varying the field intensity and/or alternating the polarity of the second magnetic layer 606b a vertical vibration of the platform 604 can be induced. The vibrational frequency is determined by the rate of change of the magnetic properties, while the amplitude of the vibration is determined by the magnetic field intensity. Additionally, the magnetic field intensity may be increased or decreased as needed, depending on a patient's weight, to properly position and vibrate the platform 604. In embodiments, plat form 604 vibrates vertically with a frequency of between 0 Hz and 10 KHz.
First elastic layer 610 is configured to create support and fit within system 600. The first elastic layer 610 can be any elastomeric material such as rubber, cloth/rubber combinations, or soft elastic material, such as foamed polyurethane (PU). The first elastic layer 610 may have a suitable density, so that it is readily deformed when being squeezed and able to recover quickly and freely from squeezing. The main body of the first elastic layer 610 may have an overall height or size properly decided depending on a use intended for it. For example, it may be 1 mm to 5 cm in height for suitably positioning in system 600.
Referring to
Second elastic layer 730 is configured to create support and fit within system 700. The second elastic layer 730 can be any elastomeric material such as rubber, cloth/rubber combinations, or soft elastic material, such as foamed polyurethane (PU). The second elastic layer 730 may have a suitable density, so that it is readily deformed when being squeezed and able to recover quickly and freely from squeezing. The main body of the second elastic layer may have an overall height or size properly decided depending on a use intended for it. For example, it may be 1 mm to 5 cm in height for suitably positioning in system 700.
Referring to
Aligned directly below the first magnetic layer 806 is a second elastic layer 830. Second elastic layer 830 is configured to create support and fit within system 800. The second elastic layer 830 can be any elastomeric material such as rubber, cloth/rubber combinations, or soft elastic material, such as foamed polyurethane (PU). The second elastic layer 830 may have a suitable density, so that it is readily deformed when being squeezed and able to recover quickly and freely from squeezing. The main body of the second elastic layer may have an overall height or size properly decided depending on a use intended for it. For example, it may be 1 mm to 5 cm in height for suitably positioning in system 800.
Positioned adjacent to the second elastic layer 830 is second magnetic layer 808 configured for generating a magnetic field, which is controllable as described above for the embodiment in
Additionally, a third magnetic layer 811 configured for generating a magnetic field is positioned along at least one side of the platform 804. As with the first magnetic layer 806, the third magnetic layer 810 can be made from permanent Ferro-magnetic materials and/or any suitable magnetic material such as one or more static or dynamic ferromagnetic objects, electromagnets, flexible magnets, injection molded magnets, neodymium iron boron magnets, samarium cobalt magnets, alnico magnets, ceramic magnets, or combinations thereof.
A fourth magnetic layer configured for generating a magnetic field 812 is located and aligned opposite the third magnetic layer 811 on a side wall of the cavity of the low profile base 802. The fourth magnetic layer 812 is controllable in the same manner as described for the second magnetic layer 808, such that a controlled horizontal vibration is imparted on the platform 804. By alternating the magnetic polarity of the fourth magnetic layer 812, a horizontal vibration of the platform 804 is induced. Additional magnet sets may be placed on a perpendicular side of the platform 804 and cavity wall to induce a third dimension of vibration of the platform 804. Moreover, stops 822 can be added to platform 802 to limit the movement of platform 804.
In embodiments, the field intensity and/or alternating of the polarity of the fourth magnetic layer 812 is configured for imparting periodic vibrations at a predetermined frequency to the platform 804. Accordingly, in embodiments, the platform 804 vibrates horizontally with a frequency of between 0 Hz and 10 KHz. In particular embodiments, the platform 804 vibrates horizontally with a frequency of about 30 Hz.
Body ailments or tissue conditions such as vascular diseases or disorders are alleviated, prevented and/or treated in accordance with the present disclosure by the application of one or more vibrating plates to the surface of the patient's body. The vibrating mechanism can be applied to skin adjacent to the body ailment for duration sufficient to reduce or eliminate undesirable ailments or conditions. As used herein the word “treat,” “treating” or “treatment” refers to using the apparatus of the present disclosure prophylactically to prevent outbreaks of one or more undesirable ailments and/or tissue conditions, or therapeutically to ameliorate an existing ailment and/or tissue condition. A number of different treatments are now possible, which reduce and/or eliminate ailments or conditions such as vascular disease, deep vein thrombosis, orthostatic intolerance, reduced blood flow, weak bone structure, orthostatic hypotension, other tissue conditions, or combinations thereof.
As used herein “ailment” refers to any body disorder or tissue condition such as circulatory disease, vascular disease including peripheral vascular disease, cardiac disease and/or orthostatic intolerance. A used herein “vascular disease” refers to any disease of the blood vessels. As used herein “peripheral vascular disease” refers to diseases of blood vessels outside the heart and brain, including but not limited to, narrowing of vessels that carry blood to leg and arm muscles, and/or which may cause pain in exercising or walking. As used herein “orthostatic intolerance” refers to the symptoms during upright standing relieved by recumbency, as well as illnesses that contribute thereto.
Non-limiting examples of vascular disorders include acrocyanosis, arteriovenous fistula, blood clots in the veins, blood clotting disorders, Buerger's Disease, central venous insufficiency, chronic venous insufficiency, deep vein thrombosis (DVT), erythromelalgia, gangrene, ischemia such as to the fingers, hands, toes, and feet, Klippel-Trenaunay Syndrome, lymphedema, lipedema, peripheral vascular/arterial disease, thrombophlebitis/phlebitis, peripheral artery disease, peripheral venous disease, phlebitis and thrombosis, Raynaud's Disease/phenomenon, varicose and spider veins, vasculitis, venostasis, and combinations thereof.
Non-limiting examples of cardiac disease include angioneurotic edema, behcet syndrome, cardiac tamponade, cardiomegaly, cardimyopathy (dilated, hypertrophic, restrictive), cardiovascular disease, cartoid stenosis, Churg Strauss Syndrome, Ebstein's anomaly, Eisenmenger Complex, embolism (cholesterol), endocarditis, fibromuscular dysplasia, heart diseases, hematoma, Hippel-Lindau Disease, hyperemia, hypertension, hypotension, intermittent claudication, intracranial aneurysm, Klippel-Trenaunay-Weber Syndrome, long XT syndrome, microvascular angina, moyamoya disease, mucocutaneous lymph node syndrome, phlebitis, polyarteritis nodosa, pulmonary atresia, Raynaud disease, Sneddon Syndrome, Takayasu's Arteritis, telangiectasia (hereditary hemorrhagic), telangiectassis, temporal arteritis, thromboangitis obliterans, thrombophlebitis, thrombosis, vasculitis, vasospasm, Williams Syndrome, Wolff-Parkinson-White Syndrome, and combinations thereof.
Non-limiting examples of illnesses that contribute to orthostatic intolerance include disorders of blood flow, heart rate and blood pressure regulation that are present in any position of the patient.
Other ailments or conditions such as fibromyalgia are suitable for treatment in accordance with the present disclosure.
In embodiments, the apparatus for use in accordance with the present disclosure provides vibrations in an effective amount to improve an ailment and/or condition. As used herein “effective amount” refers to an amount of vibration in accordance with the present disclosure that is sufficient to induce a particular positive benefit to a patient having an ailment. The positive benefit can be health-related, or it may be more cosmetic in nature, or it may be a combination of the two. In embodiments, the positive benefit is achieved by contacting the patient's body with vibrations to improve one or more ailments or tissue conditions. In embodiments, the positive benefit is achieved by contacting skin with one or more vibrating plates to alleviate symptoms caused by vascular disease, deep vein thrombosis, orthostatic intolerance, reduced blood flow, weak bone structure, orthostatic hypotension, other conditions, and combinations thereof. In embodiments, the positive benefit is achieved by applying vibrations and magnetic field to cure an ailment or tissue condition.
The particular magnetic field, and the vibration frequency employed, generally depends on the purpose for which the treatment is to be applied. For example, the duration and vibration frequency of application can vary depending upon the type and severity of the ailment.
In order to facilitate use of the device for providing vibrational energy while performing every day tasks, the device can be incorporated into various fixed positions. For example, the low profile base can be placed into various objects such as shoes, socks, sandals and the like. Moreover, the low profile base can be positioned upon or within flooring such as the floor of a car, bus, train, plane and the like. Referring to
Referring now to
In embodiments, the low profile base 1002 is configured to be inserted and/or built into a shoe or sandal like apparatus. Accordingly, the low profile base 1002 can be configured as a mid-sole or layer between the insole and/or platform 1004, or configured as a portion of an outsole in direct contact with the ground. Accordingly, the low profile base has a thickness of about 1 mm to about 10 cm, and in particular embodiments about 5 mm. Accordingly, the low profile base 1002 may be made out of any material suitable for supporting the weight of a user standing thereon, including but not limited to rubber, polymer, foam, plastic, thermoplastic, cork or similar material and/or combinations thereof.
In embodiments, the first magnetic layer 1006a below first elastic layer 1010 includes static magnetic field generating devices, such as permanent Ferro-magnets, but may also include electromagnets, coils, or dynamic magnetic field generating devices. In embodiments, the first magnetic layer 1006a is made of any suitable magnetic material such as one or more static ferromagnetic objects, electromagnets, flexible magnets, injection molded magnets, neodymium iron boron magnets, samarium cobalt magnets, alnico magnets, ceramic magnets, or combinations thereof. In one particular embodiment, first magnetic layer 1006a is a flexible magnet configured to cover the underside of the first elastic layer 1010. In embodiments, the first magnetic layer 1006a can have a thickness of about 1 mm to about 5 cm.
The second magnetic layer 1006b, can be a set of electromagnets, coils, or other dynamic magnetic field generating devices. In embodiments, the second magnetic layer 1006b, can be one or more static or dynamic ferromagnetic objects, electromagnets, flexible magnets, injection molded magnets, neodymium iron boron magnets, samarium cobalt magnets, alnico magnets, ceramic magnets, or combinations thereof. In one particular embodiment, second magnetic layer 1006b is a flexible magnet configured to coat or cover the low platform base 1002. In embodiments, the second magnetic layer can have a thickness of about 1 mm to about 5 cm.
By varying the field intensity and/or alternating the polarity of the second magnetic layer 1006b a vertical vibration of the platform 1004 can be induced. The vibrational frequency is determined by the rate of change of the magnetic properties, while the amplitude of the vibration is determined by the magnetic field intensity. Additionally, the magnetic field intensity may be increased or decreased as needed, depending on a patient's weight, to properly position and vibrate the platform 1004. In embodiments, platform 1004 vibrates vertically with a frequency of between 0 Hz and 10 KHz.
First elastic layer 1010 is configured to create support and fit within system 1000. The first elastic layer 1010 can be any elastomeric material such as rubber, cloth/rubber combinations, or soft elastic material, such as foamed polyurethane (PU). The first elastic layer 1010 may have a suitable density, so that it is readily deformed when being squeezed and able to recover quickly and freely from squeezing. The main body of the first elastic layer 1010 may have an overall height or size properly decided depending on a use intended for it. For example, it may be 1 mm to 5 cm in height for suitably positioning in system 1000.
Referring now to
Optionally, as best shown in
Referring now to
Base 1020 can have a variety of shapes and made of a variety of materials such as plastic, thermoplastic, polymer, rubber, cork, wood, and other materials known in the art. The base 1020 material should be stiff enough and durable enough to withstand the weight of the user after numerous uses where a user is standing on the system 1000 disposed upon the base 1020.
Referring now to
Still referring to
Referring to
The following non-limiting prophetic examples further illustrate methods in accordance with this disclosure.
A 52 year old woman is suffering from deep vein thrombosis (DVT) in her left calf. A vibrating plate suitable for treatment of deep vein thrombosis (DVT) is routinely applied to her calf twice daily. The plate vibrates against the calf at a frequency of about 30 KHz for 10 minutes per application. Blood flow throughout the calf is increased.
A 45 year old man is suffering from deep vein thrombosis (DVT) in his right leg. A vibrating plate in accordance with the present disclosure and suitable for treatment of deep vein thrombosis (DVT) is routinely applied to the bottom of his right foot three times a day. The plate vibrates against the foot at a frequency of about 30 KHz for 5 minutes per application. Blood flow throughout the right leg is increased.
A 55 year old man is suffering from orthostatic intolerance. While sitting, a vibrating plate in accordance with the present disclosure is routinely applied to the bottom of his right and left feet three times a day. The plate vibrates against the feet at a frequency of about 30 KHz for 5 minutes per application. Blood flow throughout both legs is increased, and orthostatic intolerance subsides.
A 75 year old woman is suffering from vascular disease, namely peripheral venous disease. Blood flow throughout her legs is poor. While sitting, a vibrating plate in accordance with the present disclosure is routinely applied to the bottom of her feet four times a day. The plate vibrates against the feet at a frequency of about 25 KHz for 10 minutes per application. Blood flow throughout both legs is increased, and peripheral venous disease is alleviated.
A 45 year old woman is suffering from vascular disease, namely peripheral venous disease. Blood flow throughout her legs is poor. While sitting in the passenger seat of a car and commuting to work she rests her feet on a vibrating plate in accordance with the present disclosure. The plate vibrates against the feet at a frequency of about 30 Hz for 20 minutes while she commutes to work. Blood flow throughout both legs is increased, and peripheral venous disease is alleviated.
A 45 year old man is suffering from deep vein thrombosis (DVT) in his right leg. Three times a day the man places his foot into an apparatus in accordance with the present disclosure by placing his toes under an upper and activating the device. The system vibrates and treats the deep vein thrombosis (DVT) The plate vibrates against the foot at a frequency of about 30 KHz for 5 minutes per application. Blood flow throughout the right leg is increased. Incidence if DVT is decreased.
A 55 year old man is suffering from deep vein thrombosis (DVT) in his right and left leg. Three times a day the man places his foot into two socks, each sock containing a device in accordance with the present disclosure at the bottom. The devices vibrate and treat the deep vein thrombosis (DVT) The plates vibrate against the feet at a frequency of about 30 Hz for 5 minutes per application. Blood flow throughout both the right leg and left leg is increased. Incidence if DVT in both legs is decreased.
The described embodiments of the present disclosure are intended to be illustrative rather than restrictive, and are not intended to represent every embodiment of the present disclosure. Various modifications and variations can be made without departing from the spirit or scope of the present disclosure as set forth in the following claims both literally and in equivalents recognized in law.
This patent application claims priority to a provisional application filed on Jul. 11, 2006 and assigned U.S. Provisional Application Ser. No. 60/830,286; the entire contents of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1125931 | Roche | Jan 1915 | A |
1945675 | Binney | Feb 1934 | A |
2193978 | Miller | Mar 1940 | A |
2345439 | Tompkins | Mar 1944 | A |
2779328 | Grossi | Jan 1957 | A |
2845063 | Allen | Jul 1958 | A |
2902993 | Wagner | Sep 1959 | A |
2916745 | Lesk et al. | Dec 1959 | A |
3134451 | Hanssen | May 1964 | A |
3193034 | Hutchinson et el. | Jul 1965 | A |
3304036 | Davis | Feb 1967 | A |
3304449 | Pohlman et at. | Feb 1967 | A |
3499437 | Balamuth | Mar 1970 | A |
3581739 | Brandt et al. | Jun 1971 | A |
3593239 | Hofman | Jul 1971 | A |
3760799 | Crowson | Sep 1973 | A |
3762402 | Abramovitz | Oct 1973 | A |
3765407 | Prince | Oct 1973 | A |
3767195 | Dimick | Oct 1973 | A |
3841320 | Brown, Jr. | Oct 1974 | A |
3890953 | Kraus et al. | Jun 1975 | A |
3911907 | Smith, Jr. | Oct 1975 | A |
3961380 | Garr | Jun 1976 | A |
4013069 | Hasty | Mar 1977 | A |
4105017 | Ryaby et al. | Aug 1978 | A |
4232661 | Christensen | Nov 1980 | A |
4266532 | Ryaby et al. | May 1981 | A |
4266533 | Ryaby et al. | May 1981 | A |
4315503 | Ryaby et al. | Feb 1982 | A |
4326506 | Kawabata | Apr 1982 | A |
4358105 | Sweeney, Jr. | Nov 1982 | A |
4369537 | Midgley | Jan 1983 | A |
4381040 | Brouwer | Apr 1983 | A |
D269305 | Nakao et al. | Jun 1983 | S |
4446586 | Reed et al. | May 1984 | A |
4452326 | Hanssen et al. | Jun 1984 | A |
4530360 | Duarte | Jul 1985 | A |
4570927 | Petrofsky et al. | Feb 1986 | A |
4669483 | Hepp et al. | Jun 1987 | A |
4687195 | Potts | Aug 1987 | A |
4697581 | Endo et al. | Oct 1987 | A |
4710655 | Masaki | Dec 1987 | A |
4750574 | Williams | Jun 1988 | A |
4782822 | Ricken | Nov 1988 | A |
4787888 | Fox | Nov 1988 | A |
4788968 | Rudashevsky et al. | Dec 1988 | A |
D299787 | Bates | Feb 1989 | S |
4836316 | Carnevale et al. | Jun 1989 | A |
4858599 | Halpern et al. | Aug 1989 | A |
4890953 | Malatesta | Jan 1990 | A |
4905671 | Senge et al. | Mar 1990 | A |
4913248 | Zakai | Apr 1990 | A |
4917376 | Lo | Apr 1990 | A |
4927138 | Ferrari | May 1990 | A |
4928959 | Bassett et al. | May 1990 | A |
4986534 | Meier et al. | Jan 1991 | A |
5000442 | Dalebout et al. | Mar 1991 | A |
5003965 | Talish et al. | Apr 1991 | A |
5046484 | Bassett et al. | Sep 1991 | A |
5103806 | McLeod et al. | Apr 1992 | A |
5107540 | Mooney et al. | Apr 1992 | A |
5108452 | Fallin | Apr 1992 | A |
5113850 | Larremore et al. | May 1992 | A |
5133420 | Smith | Jul 1992 | A |
5145027 | Petzl et al. | Sep 1992 | A |
5186162 | Talish et al. | Feb 1993 | A |
5188095 | Healy | Feb 1993 | A |
5191880 | McLeod et al. | Mar 1993 | A |
5211160 | Talish et al. | May 1993 | A |
5255957 | Opsvik et al. | Oct 1993 | A |
5273028 | McLeod et al. | Dec 1993 | A |
5273502 | Kelsey et al. | Dec 1993 | A |
5295931 | Dreibelbis et al. | Mar 1994 | A |
5318561 | McLeod et al. | Jun 1994 | A |
RE34663 | Seale | Jul 1994 | E |
5335188 | Brisson | Aug 1994 | A |
5336144 | Rodden | Aug 1994 | A |
5337757 | Jain et al. | Aug 1994 | A |
5339804 | Kemp | Aug 1994 | A |
5351389 | Erickson et al. | Oct 1994 | A |
5368044 | Cain et al. | Nov 1994 | A |
5376065 | McLeod et al. | Dec 1994 | A |
5380269 | Urso | Jan 1995 | A |
5409446 | Rattner | Apr 1995 | A |
RE34959 | Potts | May 1995 | E |
5429585 | Liang | Jul 1995 | A |
5431612 | Holden | Jul 1995 | A |
5437668 | Aronson et al. | Aug 1995 | A |
5466215 | Lair et al. | Nov 1995 | A |
5468220 | Sucher | Nov 1995 | A |
5478306 | Stoner | Dec 1995 | A |
5484388 | Bassett et al. | Jan 1996 | A |
5492525 | Gibney | Feb 1996 | A |
5496256 | Bock et al. | Mar 1996 | A |
5501657 | Feero | Mar 1996 | A |
5520612 | Winder et al. | May 1996 | A |
5520614 | McNamara et al. | May 1996 | A |
5538489 | Magid | Jul 1996 | A |
5556372 | Talish et al. | Sep 1996 | A |
5578060 | Pohl et al. | Nov 1996 | A |
5602432 | Mizutani | Feb 1997 | A |
5626554 | Ryaby et al. | May 1997 | A |
5702353 | Guzzini et al. | Dec 1997 | A |
5708236 | Shaanan et al. | Jan 1998 | A |
5716331 | Chang | Feb 1998 | A |
5721400 | Haraldsson et al. | Feb 1998 | A |
5730705 | Talish et al. | Mar 1998 | A |
5741317 | Ostrow | Apr 1998 | A |
5755746 | Lifshey et al. | May 1998 | A |
5762616 | Talish | Jun 1998 | A |
5779600 | Pape | Jul 1998 | A |
5797860 | Moriyasu | Aug 1998 | A |
5868649 | Erickson et al. | Feb 1999 | A |
5871446 | Wilk | Feb 1999 | A |
5886302 | Germanton et al. | Mar 1999 | A |
5904659 | Duarte et al. | May 1999 | A |
5910123 | Wang et al. | Jun 1999 | A |
5913838 | Reilly | Jun 1999 | A |
5957814 | Eschenbach | Sep 1999 | A |
5971984 | Taylor et al. | Oct 1999 | A |
5987982 | Wenman et al. | Nov 1999 | A |
5997490 | McLeod et al. | Dec 1999 | A |
6019710 | Dalebout et al. | Feb 2000 | A |
6022349 | McLeod et al. | Feb 2000 | A |
D421828 | Malka | Mar 2000 | S |
6050364 | Popall et al. | Apr 2000 | A |
6061597 | Rieman et al. | May 2000 | A |
6063046 | Allum | May 2000 | A |
6068596 | Weth et al. | May 2000 | A |
6080088 | Petersen et al. | Jun 2000 | A |
6086078 | Ferez | Jul 2000 | A |
6093135 | Huang | Jul 2000 | A |
6106491 | Gianutsos | Aug 2000 | A |
6116691 | Reece | Sep 2000 | A |
6119291 | Osborne et al. | Sep 2000 | A |
6179797 | Brotz | Jan 2001 | B1 |
6234975 | McLeod et al. | May 2001 | B1 |
6258020 | Lopez | Jul 2001 | B1 |
6346088 | Stone et al. | Feb 2002 | B1 |
6421935 | Bartlett | Jul 2002 | B1 |
6440046 | Tholkes | Aug 2002 | B1 |
D467407 | Berg et al. | Dec 2002 | S |
D471346 | Bray, Jr. et al. | Mar 2003 | S |
6558304 | Bardon et al. | May 2003 | B1 |
6561991 | McLeod et al. | May 2003 | B2 |
6607497 | McLeod et al. | Aug 2003 | B2 |
6610021 | Bock | Aug 2003 | B1 |
6620117 | Johnson et al. | Sep 2003 | B1 |
6632158 | Nashner | Oct 2003 | B1 |
6656137 | Tyldsley et al. | Dec 2003 | B1 |
6843776 | Trandafir et al. | Jan 2005 | B2 |
6884227 | Krompasick | Apr 2005 | B2 |
6902320 | McKenna | Jun 2005 | B2 |
6923773 | Leivseth et al. | Aug 2005 | B2 |
7094211 | Krompasick | Aug 2006 | B2 |
7100439 | Carlucci | Sep 2006 | B2 |
7108663 | Talish et al. | Sep 2006 | B2 |
7152345 | Koenig | Dec 2006 | B2 |
7166067 | Talish et al. | Jan 2007 | B2 |
7207954 | Trandafir et al. | Apr 2007 | B2 |
7207955 | Krompasick | Apr 2007 | B2 |
7211060 | Talish et al. | May 2007 | B1 |
7322948 | Talish et al. | Jan 2008 | B2 |
D564734 | Krompasick et al. | Mar 2008 | S |
7338457 | Talish et al. | Mar 2008 | B2 |
7347831 | Chiu | Mar 2008 | B2 |
7402144 | McLeod | Jul 2008 | B2 |
7491183 | Dalen | Feb 2009 | B2 |
7525403 | Kim | Apr 2009 | B2 |
7670304 | Kim | Mar 2010 | B2 |
7771375 | Nishibori et al. | Aug 2010 | B2 |
7942835 | Talish et al. | May 2011 | B2 |
8043234 | Talish et al. | Oct 2011 | B2 |
8114036 | Krompasick | Feb 2012 | B2 |
20010000782 | Schiessl | May 2001 | A1 |
20020077570 | McLeod et al. | Jun 2002 | A1 |
20020183662 | Lu | Dec 2002 | A1 |
20030083599 | Kitov | May 2003 | A1 |
20030090374 | Quigley | May 2003 | A1 |
20040059331 | Mullaney | Mar 2004 | A1 |
20040067833 | Talish et al. | Apr 2004 | A1 |
20040068211 | Leivseth et al. | Apr 2004 | A1 |
20040092848 | Trandafir et al. | May 2004 | A1 |
20040092849 | Talish | May 2004 | A1 |
20040260211 | Maalouf | Dec 2004 | A1 |
20050026750 | Oglesby et al. | Feb 2005 | A1 |
20050131319 | Der Meer Guus | Jun 2005 | A1 |
20050148911 | Talish et al. | Jul 2005 | A1 |
20050154334 | Trandafir et al. | Jul 2005 | A1 |
20050193820 | Sheljaskow et al. | Sep 2005 | A1 |
20050251068 | Mor | Nov 2005 | A1 |
20060047230 | Talish | Mar 2006 | A1 |
20060076816 | Fujita et al. | Apr 2006 | A1 |
20060111652 | McLeod | May 2006 | A1 |
20060155221 | Kim | Jul 2006 | A1 |
20060200054 | Talish et al. | Sep 2006 | A1 |
20060217640 | Trandafir | Sep 2006 | A1 |
20060241528 | Talish | Oct 2006 | A1 |
20070021693 | Trandafir et al. | Jan 2007 | A1 |
20070027410 | Cost | Feb 2007 | A1 |
20070038165 | Trandafir et al. | Feb 2007 | A1 |
20070043310 | Trandafir et al. | Feb 2007 | A1 |
20070055185 | Trandafir et al. | Mar 2007 | A1 |
20070073196 | Tanaka et al. | Mar 2007 | A1 |
20070184953 | Luberski et al. | Aug 2007 | A1 |
20070213179 | Trandafir | Sep 2007 | A1 |
20070219473 | Talish et al. | Sep 2007 | A1 |
20070232965 | Talish | Oct 2007 | A1 |
20070260161 | Trandafir et al. | Nov 2007 | A1 |
20080009776 | Trandafir | Jan 2008 | A1 |
20080015476 | Talish et al. | Jan 2008 | A1 |
20080015477 | Talish et al. | Jan 2008 | A1 |
20080139977 | Talish et al. | Jun 2008 | A1 |
20080139978 | Talish et al. | Jun 2008 | A1 |
20080139979 | Talish et al. | Jun 2008 | A1 |
20080214971 | Talish et al. | Sep 2008 | A1 |
20090062698 | Einav et al. | Mar 2009 | A1 |
20090228229 | Trandafir | Sep 2009 | A1 |
20100152819 | McLeod | Jun 2010 | A1 |
Number | Date | Country |
---|---|---|
667113 | Jul 1996 | AU |
2006226886 | Mar 2011 | AU |
2136012 | May 2004 | CA |
2463376 | Jan 2008 | CA |
2504459 | Jan 2008 | CA |
2531570 | Sep 2009 | CA |
2602040 | Mar 2013 | CA |
323 767 | Aug 1957 | CH |
ZL200380102816.5 | Sep 2008 | CN |
ZL200710165664.3 | Aug 2011 | CN |
15 66 521 | Mar 1971 | DE |
32 27 519 | Feb 1983 | DE |
94 10 902 | Nov 1995 | DE |
196 39 477 | Apr 1998 | DE |
102 01 255 | Jul 2003 | DE |
0029298 | May 1981 | EP |
0 695 559 | Feb 1996 | EP |
1 026 484 | Aug 2000 | EP |
1 400 264 | Mar 2004 | EP |
1656921 | May 2006 | EP |
1455725 | Jun 2006 | EP |
2 562 446 | Oct 1985 | FR |
2562446 | Oct 1985 | FR |
60150749 | Aug 1985 | JP |
62-72359 | Apr 1987 | JP |
2-60608 | Mar 1990 | JP |
U 2-32830 | Mar 1990 | JP |
U 4-3736 | Jan 1992 | JP |
04-504666 | Aug 1992 | JP |
5317376 | Dec 1993 | JP |
7507224 | Aug 1995 | JP |
3036291 | Jan 1997 | JP |
3038101 | Jun 1997 | JP |
11319144 | Nov 1999 | JP |
2000-60978 | Feb 2000 | JP |
3069745 | Apr 2000 | JP |
2001-000496 | Jan 2001 | JP |
2001-017493 | Jan 2001 | JP |
2001-070383 | Mar 2001 | JP |
2001-513352 | Sep 2001 | JP |
2001-517134 | Oct 2001 | JP |
2001-346846 | Dec 2001 | JP |
2002-153349 | May 2002 | JP |
2002-306559 | Oct 2002 | JP |
2002-325808 | Nov 2002 | JP |
2003-102801 | Apr 2003 | JP |
3547742 | Apr 2004 | JP |
2004-321665 | Nov 2004 | JP |
2004-337275 | Dec 2004 | JP |
2005-512721 | May 2005 | JP |
0225300 | Jul 1999 | KR |
10-0974673 | Aug 2010 | KR |
183314 | Nov 1996 | MX |
584 842 | Dec 1977 | SU |
WO 9324092 | Dec 1993 | WO |
WO 9521580 | Aug 1995 | WO |
WO 9603104 | Feb 1996 | WO |
WO 02053084 | Jul 2002 | WO |
WO 03030805 | Apr 2003 | WO |
WO 03055389 | Jul 2003 | WO |
WO 2004043324 | May 2004 | WO |
WO 2004096108 | Nov 2004 | WO |
WO 2004103244 | Dec 2004 | WO |
WO 2005000188 | Jan 2005 | WO |
WO 2005115298 | Dec 2005 | WO |
WO 2006001656 | Jan 2006 | WO |
WO 2006023817 | Mar 2006 | WO |
WO 2006096662 | Sep 2006 | WO |
WO 2006096734 | Sep 2006 | WO |
WO 2006096734 | Sep 2006 | WO |
WO 2006102582 | Sep 2006 | WO |
WO 2007011885 | Jan 2007 | WO |
WO 2007015748 | Feb 2007 | WO |
WO 2007015856 | Feb 2007 | WO |
WO 2007015749 | Feb 2007 | WO |
WO 2007103413 | Sep 2007 | WO |
WO 2007103414 | Sep 2007 | WO |
WO 2007103415 | Sep 2007 | WO |
WO 2007103516 | Sep 2007 | WO |
WO 2008008317 | Jan 2008 | WO |
WO 2008008340 | Jan 2008 | WO |
WO 2008070826 | Jun 2008 | WO |
WO 2009023432 | Feb 2009 | WO |
WO 2009073881 | Jun 2009 | WO |
WO 2009111561 | Sep 2009 | WO |
Entry |
---|
Holmlund et al., “Mechanical impedance of the human body in vertical direction”, Applied Ergonomics, Elsevier Science Ltd. (2000). |
Wei et al., “The Prediction of Seat Transmissiblity from Measures of Seat Impedance”, Journal of Sound and Vibration, 214(1), pp. 121-137 (1998). |
PCT International Search Report and Written Opinion for PCT/US2007/015694 dated Dec. 21, 2007. |
PCT International Search Report for PCT/US2007/015732 dated Jan. 24, 2008. |
PCT International Search Report (ISR) for PCT/US2006/027723, Oct. 30, 2006, European Patent Office. |
Edward, V., PCT International Search Report (ISR) for PCT/US2006/008132. Jul. 2, 2006, European Patent Office. |
Artikis, T., PCT International Search Report (ISR) for PCT/US2006/010753. Jul. 20, 2006, European Patent Office. |
Fischer, E., PCT International Search Report (ISR) for PCT/US2006/007983. Jul. 13, 2006, European Patent Office. |
Yu, J., International Preliminary Report on Patentability (IPRP) for PCT/US06/07983. Apr. 20, 2007, Alexandria, VA. |
Fischer, E., PCT International Search Report (ISR) for PCT/US2006/027355. Oct. 26, 2006, European Patent Office. |
Fischer, E., PCT International Search Report (ISR) for PCT/US2006/027832, Oct. 26, 2006, European Patent Office. |
Pope, M.H. et al., “Mounting of the Transducers in Measurement of Segmental Motion of the Spine,” J. Biomechanics, 1986, pp. 675-677, vol. 19, No. 8. |
Jordan, J., “Good Vibrations and Strong Bones,” Am. J. Physiol. Reful. Integr. Comp. Physiol., 288 (3): R555-556 (2005). |
Stewart, J.M. et al., “Plantar vibration improved leg fluid . . . ,” The American Journal of Phgy—Reg, Integ and Comp Phgy, Oct. 7, 2004, 288:R623-R629, New York, NY. |
Bassett et al: “Generation of Electric Potentials by Bone in Response to Mechanical Stress,” Science Magazine, 137, pp. 1063-64 (1962). |
PCT International Search Report dated Aug. 30, 2007 for PCT/US2007/005793 (Aug. 30, 2007). |
PCT notification of transmittal of the ISR and Written Opinion of ISA for PCT/US2007/005794 (Aug. 30, 2007). |
PCT notification of transmittal of the ISR and Written Opinion of ISA for PCT/US2007/005792 (Sep. 12, 2007). |
PCT International Search Report (ISR) for PCT/US2007/015732 (Jan. 24, 2008). |
Goodard at al.: “Reversal of Lower-limb Edema by Calf Muscle Pump Stimulation,”. J. Cardiopulmonary Rehab. & Prevention, 28:174-179 (May/Jun. 2008). |
Walsh, W.R, at al,: “Influence of Dynamic Motion Therapy on bone ingrowth into a bone graft substitute”, Surg. & Ortho. Res, Labs., Univ. of New S. Wales, w.walsh@unsw.edu.au. |
Number | Date | Country | |
---|---|---|---|
20080015477 A1 | Jan 2008 | US |
Number | Date | Country | |
---|---|---|---|
60830286 | Jul 2006 | US |